BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.470
+0.010 (0.68%)
Apr 17, 2026, 9:36 AM EDT - Market open
BioVie Market Cap
BioVie has a market cap or net worth of $11.08 million as of April 17, 2026. Its market cap has decreased by -38.76% in one year.
Market Cap
11.08M
Enterprise Value
-9.22M
1-Year Change
-38.76%
Ranking
Category
Stock Price
$1.47
Market Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $11.08M, a decrease of -78.68%. That is a compound annual growth rate of -24.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 10.60M | 21.84% |
| Dec 31, 2025 | 8.70M | -75.49% |
| Dec 31, 2024 | 35.50M | -25.42% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
| Sep 18, 2020 | 52.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Soligenix | 11.85M |
| NewcelX | 11.81M |
| Quoin Pharmaceuticals | 11.60M |
| CytoMed Therapeutics | 11.59M |
| Theriva Biologics | 11.44M |
| Genprex | 11.17M |
| Reviva Pharmaceuticals Holdings | 11.11M |
| Aprea Therapeutics | 10.88M |